Growing Facility Investment STAQ Pharma has recently invested $50 million into new compounded medications production facilities in Columbus, Ohio, signaling expanding manufacturing capacity and increasing supply chain robustness, which presents opportunities to supply complementary pharmaceutical components or advanced packaging solutions.

Expanding Market Reach With licensing nationwide and shipping to over 800 healthcare locations monthly, STAQ Pharma demonstrates a broad distribution network, opening avenues for sales of supply chain optimization tools, inventory management systems, or logistics services.

Strategic Partnerships Collaborations with major healthcare providers like University Hospitals and partnerships with children's hospitals indicate a focus on specialized and high-need healthcare segments, suggesting opportunities in providing tailored formulations, innovative drug delivery systems, or patient safety technology.

Recent Capital Investment Receiving a total funding of $30 million and generating revenues between $50 to $100 million, STAQ Pharma is positioned for growth, making it an ideal candidate for vendors offering advanced manufacturing equipment, process automation, or quality assurance solutions.

Recognition and Awards Having received the 2019 Project Achievement Award for healthcare facility development, STAQ Pharma values quality and innovation, which can facilitate sales of cutting-edge construction, infrastructure, or compliance technology solutions to support ongoing facility upgrades.